BioWorld Asia

Nov. 28, 2007

NeuroSearch Nets $145M In Discounted Rights Issue

NeuroSearch A/S has completed one of Europe's biggest biotechnology fundraisings in 2007, netting DKK728.7 million (US$145.2 million) in a discounted rights issue. (BioWorld International) Read More

GW Pharmaceuticals Launches Sativex Pain Trials In The U.S.

Study Challenges Models Of How Cancer Spreads

UK's Stabilitech Claims Method To Prevent Spoilage Of Vaccines

EU, FDA Agree To Simplify Process For Orphan Drugs

GPC Cuts Staff 44 Percent To Conserve Operating Cash

Other News To Note

Opsona Licenses Breast Milk Immunomodulatory Protein

Fovea Enters Ophthalmology Collaboration with Genzyme

AMT In-Licenses Second Gene Therapy Program

Today's news in brief

BioWorld

BioWorld briefs for Dec. 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 29, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...